Combinatorial Cytokine Code Generates Anti-Viral State in Dendritic Cells

The physiological function of the immune system and the response to therapeutic immunomodulators may be sensitive to combinatorial cytokine micro-environments that shape the responses of specific immune cells. Previous work shows that paracrine cytokines released by virus-infected human dendritic cells (DC) can dictate the maturation state of naïve DCs. To understand the effects of paracrine signaling, we systematically studied the effects of combinations cytokines in this complex mixture in generating an anti-viral state. After naïve DCs were exposed to either IFNβ or to paracrine signaling released by DCs infected by Newcastle disease virus (NDV), microarray analysis revealed a large number of genes that were differently regulated by the DC-secreted paracrine signaling. In order to identify the cytokine mechanisms involved, we identified 20 cytokines secreted by NDV infected DCs for which the corresponding receptor gene is expressed in naïve DCs. By exposing cells to all combinations of 19 cytokines (leave-one-out studies), we identified five cytokines (IFNβ, TNFα, IL-1β, TNFSF15, and IL28) as candidates for regulating DC maturation markers. Subsequent experiments identified IFNβ, TNFα, and IL1β as the major contributors to this anti-viral state. This finding was supported by infection studies in vitro, by T-cell activation studies and by in vivo infection studies in mouse. Combination of cytokines can cause response states in DCs that differ from those achieved by the individual cytokines alone. These results suggest that the cytokine microenvironment may act via a combinatorial code to direct the response state of specific immune cells. Further elucidation of this code may provide insight into responses to infection and neoplasia as well as guide the development of combinatorial cytokine immunomodulation for infectious, autoimmune, and immunosurveillance-related diseases.

[1]  Eduardo Pauls,et al.  Two Phases of Inflammatory Mediator Production Defined by the Study of IRAK2 and IRAK1 Knock-in Mice , 2013, The Journal of Immunology.

[2]  T. Randall,et al.  CD4+ T helper cells use CD154–CD40 interactions to counteract T reg cell–mediated suppression of CD8+ T cell responses to influenza , 2013, The Journal of experimental medicine.

[3]  Paul G. Thomas,et al.  Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection , 2013, Nature Immunology.

[4]  D. Zamboni,et al.  NOD1 and NOD2 Signaling in Infection and Inflammation , 2012, Front. Immun..

[5]  Xiaobo Zhou,et al.  Cytokine combination therapy prediction for bone remodeling in tissue engineering based on the intracellular signaling pathway. , 2012, Biomaterials.

[6]  Marion C Lanteri,et al.  IL-1β Signaling Promotes CNS-Intrinsic Immune Control of West Nile Virus Infection , 2012, PLoS pathogens.

[7]  D. Holmberg,et al.  Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice , 2012, Diabetes.

[8]  J. Kos,et al.  Regulation of cathepsins S and L by cystatin F during maturation of dendritic cells. , 2012, European journal of cell biology.

[9]  J. Batra,et al.  Antimicrobial activity of human eosinophil granule proteins: involvement in host defence against pathogens , 2012, Critical reviews in microbiology.

[10]  R. Albrecht,et al.  The M Segment of the 2009 New Pandemic H1N1 Influenza Virus Is Critical for Its High Transmission Efficiency in the Guinea Pig Model , 2011, Journal of Virology.

[11]  Peter O. Krutzik,et al.  Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons , 2011, Cell.

[12]  Jianhua Xiao,et al.  The kinase activity of interleukin-1 receptor-associated kinase 2 is essential for lipopolysaccharide-mediated cytokine and chemokine mRNA stability and translation. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[13]  T. Waldmann,et al.  Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens , 2011, Nature.

[14]  M. Suárez-Fariñas,et al.  Resolved psoriasis lesions retain expression of a subset of disease-related genes. , 2011, The Journal of investigative dermatology.

[15]  S. Watowich,et al.  Mechanisms regulating dendritic cell specification and development , 2010, Immunological reviews.

[16]  M. Belvisi,et al.  TNFα and IFNγ synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-κB, and the transcriptional coactivator CREB-binding protein. , 2010, The Journal of biological chemistry.

[17]  Nikesh Kotecha,et al.  Web‐Based Analysis and Publication of Flow Cytometry Experiments , 2010, Current protocols in cytometry.

[18]  I. Kim,et al.  Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCδ activation , 2010, Molecular Biology Reports.

[19]  B. Meskó,et al.  Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets , 2010, BMC Medical Genomics.

[20]  Lawrence Steinman,et al.  T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis , 2010, Nature Medicine.

[21]  H. Wajant,et al.  TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5 , 2010, Journal of Molecular Medicine.

[22]  M. Pittelkow,et al.  Combination cytokine therapy inhibits tumor growth by generation of tumor-specific T-cell responses in a murine melanoma model. , 2010, Cytokine.

[23]  M. Kawaguchi,et al.  IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta. , 2010, American journal of physiology. Renal physiology.

[24]  G. de la Rosa,et al.  Alarmins link neutrophils and dendritic cells. , 2009, Trends in immunology.

[25]  Robert J. Vincent,et al.  The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up. , 2009, Journal of molecular and cellular cardiology.

[26]  Thomas M. Moran,et al.  Cutting Edge: Stealth Influenza Virus Replication Precedes the Initiation of Adaptive Immunity1 , 2009, The Journal of Immunology.

[27]  J. Stübgen Recombinant interferon-beta therapy and neuromuscular disorders , 2009, Journal of Neuroimmunology.

[28]  E. Shin,et al.  Immune‐based therapy for chronic hepatitis C , 2009, Journal of leukocyte biology.

[29]  E. Pamer Tipping the balance in favor of protective immunity during influenza virus infection , 2009, Proceedings of the National Academy of Sciences.

[30]  M. Caligiuri,et al.  Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells. , 2009, Blood.

[31]  Edward D. Karoly,et al.  Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line , 2008, Genomic Medicine.

[32]  Boris M. Hartmann,et al.  Antiviral-Activated Dendritic Cells: A Paracrine-Induced Response State1 , 2008, The Journal of Immunology.

[33]  H. Baker,et al.  The Addition of Tumor Necrosis Factor plus Beta Interferon Induces a Novel Synergistic Antiviral State against Poxviruses in Primary Human Fibroblasts , 2008, Journal of Virology.

[34]  T. Schwartz,et al.  Positive Versus Negative Modulation of Different Endogenous Chemokines for CC-chemokine Receptor 1 by Small Molecule Agonists through Allosteric Versus Orthosteric Binding* , 2008, Journal of Biological Chemistry.

[35]  D. Donner,et al.  Type 1 TNF Receptor Forms a Complex with and Uses Jak2 and c-Src to Selectively Engage Signaling Pathways That Regulate Transcription Factor Activity1 , 2008, The Journal of Immunology.

[36]  G. McFadden,et al.  RIG-I Mediates the Co-Induction of Tumor Necrosis Factor and Type I Interferon Elicited by Myxoma Virus in Primary Human Macrophages , 2008, PLoS pathogens.

[37]  E. Coccia IFN regulation and functions in myeloid dendritic cells. , 2008, Cytokine & growth factor reviews.

[38]  D. Moskophidis,et al.  Regulation of Immune Response and Inflammatory Reactions against Viral Infection by VCAM-1 , 2008, Journal of Virology.

[39]  P. Preshaw,et al.  The expanding family of interleukin‐1 cytokines and their role in destructive inflammatory disorders , 2007, Clinical and experimental immunology.

[40]  S. Steer,et al.  Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[41]  G. Uzé,et al.  IL-28 and IL-29: newcomers to the interferon family. , 2007, Biochimie.

[42]  C. Baldari,et al.  Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signalling , 2007, Cellular microbiology.

[43]  Clifford Liongue,et al.  Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. , 2007, Molecular immunology.

[44]  H. Pircher,et al.  Analysis of CD127 and KLRG1 Expression on Hepatitis C Virus-Specific CD8+ T Cells Reveals the Existence of Different Memory T-Cell Subsets in the Peripheral Blood and Liver , 2006, Journal of Virology.

[45]  J. Utikal,et al.  Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. , 2006, Immunobiology.

[46]  T. Gingeras,et al.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.

[47]  Thomas M. Moran,et al.  Influenza Virus Evades Innate and Adaptive Immunity via the NS1 Protein , 2006, Journal of Virology.

[48]  M. Ichinose,et al.  Agents against cytokine synthesis or receptors. , 2006, European journal of pharmacology.

[49]  N. Kajiwara,et al.  CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection , 2005, Nature Medicine.

[50]  Y. Nakanishi,et al.  Expression of B7-H1 and B7-DC on the airway epithelium is enhanced by double-stranded RNA. , 2005, Biochemical and biophysical research communications.

[51]  A. Plet,et al.  Natural, Proteolytic Release of a Soluble Form of Human IL-15 Receptor α-Chain That Behaves as a Specific, High Affinity IL-15 Antagonist1 , 2004, The Journal of Immunology.

[52]  K. Dyer,et al.  Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. , 2003, Blood.

[53]  J. O’Shea,et al.  The biology of IL-12: coordinating innate and adaptive immune responses. , 2003, Cytokine & growth factor reviews.

[54]  A. García-Sastre,et al.  Newcastle Disease Virus V Protein Is a Determinant of Host Range Restriction , 2003, Journal of Virology.

[55]  P. Insel,et al.  Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[56]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[57]  Jun Zhang,et al.  TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. , 2002, Immunity.

[58]  H. Mitsuya,et al.  Identification of Amino Acid Residues Critical for LD78β, a Variant of Human Macrophage Inflammatory Protein-1α, Binding to CCR5 and Inhibition of R5 Human Immunodeficiency Virus Type 1 Replication* , 2002, The Journal of Biological Chemistry.

[59]  A. Proudfoot Chemokine receptors: multifaceted therapeutic targets , 2002, Nature Reviews Immunology.

[60]  J. Chung,et al.  IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[61]  S. Jiang,et al.  Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptor. , 2001, Blood.

[62]  T. Huynh,et al.  RANTES Activates Jak2 and Jak3 to Regulate Engagement of Multiple Signaling Pathways in T Cells* , 2001, The Journal of Biological Chemistry.

[63]  M. Baggiolini,et al.  The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3* , 2001, The Journal of Biological Chemistry.

[64]  T. Malek,et al.  Three Loops of the Common γ Chain Ectodomain Required for the Binding of Interleukin-2 and Interleukin-7* , 2000, The Journal of Biological Chemistry.

[65]  D. Neumann,et al.  The Membrane Form of the Type II IL-1 Receptor Accounts for Inhibitory Function1 , 2000, The Journal of Immunology.

[66]  R. Doms,et al.  CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. , 1999, Blood.

[67]  A. D. de Vos,et al.  Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2. , 1999, Journal of immunology.

[68]  Stephen C. Peiper,et al.  Identification of CXCR4 Domains That Support Coreceptor and Chemokine Receptor Functions , 1999, Journal of Virology.

[69]  T. C. Wagner,et al.  Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation. , 1999, Biochemical and biophysical research communications.

[70]  A. Rees,et al.  Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. , 1998, Journal of immunology.

[71]  R. Hertzberg,et al.  Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration* , 1998, The Journal of Biological Chemistry.

[72]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[73]  C. Combadière,et al.  Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP‐1α, MIP‐1β, and RANTES , 1996, Journal of leukocyte biology.

[74]  C. Mackay,et al.  Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils , 1996, The Journal of experimental medicine.

[75]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[76]  S. Ziegler,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.

[77]  H. Nagafuchi,et al.  Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. , 1993, Journal of immunology.

[78]  P. Jorens,et al.  Cerebral arterial thrombosis preceding ulcerative colitis. , 1991, Stroke.

[79]  H. Marquardt,et al.  Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M , 1989, Molecular and cellular biology.

[80]  C. Eisenhart The assumptions underlying the analysis of variance. , 1947, Biometrics.

[81]  B. Torbett,et al.  CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation. , 2011, Molecular immunology.

[82]  I. Julkunen,et al.  TLR ligands induce synergistic interferon-β and interferon-λ1 gene expression in human monocyte-derived dendritic cells. , 2011, Molecular immunology.

[83]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[84]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.

[85]  W. Fantl,et al.  Signalling by receptor tyrosine kinases. , 1993, Annual review of biochemistry.

[86]  Interferon (cid:1) induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation , 2022 .